442 material Form 8-K filings that 386 companies we cover made with the SEC in March 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
MSA Safety said Chief Financial Officer Lee McChesney will resign effective March 21, 2025, to pursue another business opportunity, and that the departure does not involve any disagreement or accounting issues. Executive Director of Financial Planning and Analysis and Strategy Elyse Brody will serve as interim CFO while the company searches for a permanent replacement, which matters to shareholders because the company is changing its finance leadership during the search.
Lee B. McChesney resigns as SVP and CFO effective March 21, 2025; the filing says the departure is not due to any disagreement with the company or its board on operations, policies, practices or accounting.
Elyse L. Brody, 37, becomes interim CFO effective March 21, 2025, while keeping her current role; she joined the company in 2011.
The company has started a comprehensive search for a permanent CFO; the filing does not give a timeline, and Brody's pay changes are not quantified.
Fabrinet issued a warrant to an affiliate of Amazon.com, Inc. to buy up to 381,922 ordinary shares at $208.4826 per share, under a Transaction Agreement signed March 12, 2025. The company expects a non-cash charge of about $4.2 million to revenue from the warrant, which it says will reduce fully diluted EPS by about $0.12 in the fiscal third quarter ending March 28, 2025, and has revised its GAAP EPS guidance to $2.20 to $2.28.
Warrant covers up to 381,922 shares at $208.4826 per share and expires March 12, 2032; 38,192 shares vested at issuance
Expected non-cash revenue adjustment of about $4.2 million, or about $0.12 per diluted share, for the quarter ending March 28, 2025
Revised guidance: GAAP EPS $2.20 to $2.28; non-GAAP EPS $2.43 to $2.51, both on about 36.3 million fully diluted shares
Remaining warrant shares vest in tranches based on payments from Amazon or its affiliates under a commercial agreement
Cigna Group announced leadership changes effective March 31, 2025: Brian C. Evanko becomes President and Chief Operating Officer, and Ann M. Dennison becomes Executive Vice President and Chief Financial Officer. The company also reaffirmed its 2025 adjusted income from operations outlook of at least $29.50 per share, which matters to shareholders because it signals no change to prior guidance alongside a senior management reshuffle.
Evanko's effective base salary is $1,100,000, with a 2025 EIP annual target of $2,200,000 and a 2026 LTI target of $6,700,000.
Dennison's effective base salary is $800,000, with a 2025 EIP annual target of $1,100,000 and a 2026 LTI target of $3,500,000, plus a 2025-2027 transitional strategic performance share grant valued at $750,000.
Eric P. Palmer's employment as EVP for Enterprise Strategy and CEO of Evernorth Health Services ends April 26, 2025; separation terms will be reported separately.
Cigna reaffirmed 2025 adjusted income from operations of at least $29.50 per share, Evernorth pre-tax adjusted income of at least $7.2 billion, and Cigna Healthcare pre-tax adjusted income of at least $4.1 billion.
G-III Apparel reported fourth-quarter and fiscal 2025 results for the year ended January 31, 2025. Fiscal 2025 net sales rose 2.7% to $3.18 billion, and net income attributable to the company rose to $193.6 million, or $4.20 per diluted share, from $176.2 million, or $3.75, a year earlier. For fiscal 2026, the company expects net sales of about $3.14 billion and diluted EPS of $4.15 to $4.25, compared with non-GAAP EPS of $4.42 in fiscal 2025, so the outlook implies lower sales and lower non-GAAP earnings.
Fourth-quarter net sales rose 9.8% to $839.5 million; diluted EPS was $1.07 versus $0.61 a year earlier.
Fiscal 2025 non-GAAP diluted EPS was $4.42, up from $4.04; GAAP diluted EPS was $4.20, up from $3.75.
Fiscal 2026 outlook: net sales of about $3.14 billion and adjusted EBITDA of $310.0 million to $315.0 million, versus $325.9 million in fiscal 2025.
Total debt fell to $6.2 million from $417.8 million after the company redeemed the entire $400.0 million principal of its notes in August 2024.
Dollar General reported fourth-quarter fiscal 2024 net sales up 4.5% to $10.3 billion, but diluted EPS fell 52.5% to $0.87 after $232 million in store portfolio review charges, and it guided fiscal 2025 diluted EPS to $5.10 to $5.80. The company also amended its $2.375 billion revolving credit facility, which temporarily raises its leverage covenant limit, lowers its fixed charge coverage minimum, and restricts share repurchases until January 30, 2026 or earlier.
Q4 net sales rose 4.5% to $10.3 billion; same-store sales rose 1.2%, while operating profit fell 49.2% to $294.2 million.
The store portfolio review plans 96 Dollar General and 45 pOpshelf store closures and six pOpshelf conversions in fiscal 2025's first quarter.
Fiscal 2025 guidance: net sales growth of 3.4% to 4.4%, same-store sales growth of 1.2% to 2.2%, and diluted EPS of $5.10 to $5.80 (fiscal 2024 diluted EPS was $5.11).
Amendment No. 1, dated March 11, 2025, covers the revolving facility; the Board declared a $0.59 quarterly dividend payable April 22, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.